February 18, 2026

Mint, eucalyptus and chili compounds reveal powerful synergy against inflammation in immune cells

February 18, 2026 / Research update / InnovateMed Author / immune cells

by Tokyo University of Science edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Many everyday foods and seasonings—such as herbs, spices, and aromatic plants—contain natural compounds called phytochemicals that can regulate inflammatory pathways. For centuries, these ingredients have been used together in traditional cuisine and herbal […]

Mint, eucalyptus and chili compounds reveal powerful synergy against inflammation in immune cells Read More »

Mapping protein production in brain cells yields new insights for brain disease

February 18, 2026 / Research update / InnovateMed Author / brain disease

UC San Diego and Scripps Research scientists used a novel method to show that some memory neurons produce proteins at higher rates than others Peer-Reviewed PublicationUniversity of California – San Diego image: Gene Yeo, PhD view more Credit: Erik Jepsen/ UC San Diego The brain’s ability to do everything from forming memories to coordinating movement relies

Mapping protein production in brain cells yields new insights for brain disease Read More »

Predicting and preventing the risk of hip fracture related to osteoporosis

February 18, 2026 / Research update / InnovateMed Author / osteoporosis

by Universitat Pompeu Fabra – Barcelona edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source 3D-DXA FE femur model under side-way fall direction (a) and FE Strength and displacement on force-displacement plot (b). Credit: Frontiers in Bioengineering and Biotechnology (2025). DOI: 10.3389/fbioe.2025.1673339 Researchers at Pompeu Fabra University (UPF) have made a great leap

Predicting and preventing the risk of hip fracture related to osteoporosis Read More »

Weight-loss wonder pills prompt scrutiny of their key ingredient

February 18, 2026 / Research update / InnovateMed Author / Weight loss

by University of Adelaide edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Journal of Controlled Release (2026). DOI: 10.1016/j.jconrel.2026.114711 Blockbuster weight-loss drugs are transforming the way we treat obesity. But while costly injectable versions remain out of reach for many, newly approved tablet forms are expected to significantly boost access and

Weight-loss wonder pills prompt scrutiny of their key ingredient Read More »

Weight-loss drug ‘support supplements’: Do they address nutrient deficiencies, or are they just another fad?

February 18, 2026 / Patient education / InnovateMed Author / weight loss drugs

by Jordan Beaumont, The Conversation edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Yaroslav Shuraev from Pexels Weight-loss injections have rapidly moved from specialist clinics to social media feeds and high-street pharmacies. Known as GLP-1 medications, they were originally developed to support those with type 2 diabetes but are

Weight-loss drug ‘support supplements’: Do they address nutrient deficiencies, or are they just another fad? Read More »

A gel for wounds that won’t heal: Oxygen-delivering technology can prevent amputations

February 18, 2026 / Research update / InnovateMed Author / wounds

by Jules Bernstein, University of California – Riverside edited by Robert Egan Editors’ notes The GIST Add as preferred source Diagram of the self-oxygenating wound-healing technology. Credit: Iman Noshadi/UCR As aging populations and rising diabetes rates drive an increase in chronic wounds, more patients face the risk of amputations. UC Riverside researchers have developed an oxygen-delivering gel

A gel for wounds that won’t heal: Oxygen-delivering technology can prevent amputations Read More »

Nanoparticle-based gene editing could expand treatment options for cystic fibrosis

February 18, 2026 / Research update / InnovateMed Author / cystic fibrosis

by Tiare Dunlap, University of California, Los Angeles edited by Lisa Lock, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Characterization of lipid nanoparticles (LNPs) loaded with CFTR-editing cargoes. Credit: Advanced Functional Materials (2026). DOI: 10.1002/adfm.202502540 UCLA researchers have developed a lipid nanoparticle-based gene-editing approach capable of inserting an entire healthy gene into human airway cells,

Nanoparticle-based gene editing could expand treatment options for cystic fibrosis Read More »

Is exercise overrated for osteoarthritis? What the latest evidence suggests

February 18, 2026 / Research update / InnovateMed Author / osteoarthritis

by British Medical Journal edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Marcia Salido from Pexels The effectiveness of exercise therapy to ease the symptoms of osteoarthritis is likely minimal, short lived, and probably no better than no treatment at all, suggests an overarching (umbrella) systematic review and pooled

Is exercise overrated for osteoarthritis? What the latest evidence suggests Read More »

Recommendations developed for primary care asthma management in veterans, military members

February 18, 2026 / Clinical Practice / InnovateMed Author / asthma

by Elana Gotkine edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source In a synopsis of a clinical practice guideline issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Feb. 17 in the Annals of Internal Medicine, updated recommendations are presented for the primary care management

Recommendations developed for primary care asthma management in veterans, military members Read More »

Ostarine: The performance-enhancing drug giving anti-doping agencies a headache

February 18, 2026 / Clinical Practice / InnovateMed Author / ostarine

by Tom Bassindale, The Conversation edited by Lisa Lock, reviewed by Andrew Zinin The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain A drug designed to help cancer patients rebuild wasting muscles has become one of the most contentious substances in elite sport—and the scientist who discovered it now spends more time trying to stop people using

Ostarine: The performance-enhancing drug giving anti-doping agencies a headache Read More »